TELEHEALTH · PROVIDER COMPARISON
Alloy vs Midi: Prescription Speed or Clinical Depth?
One is built to get a prescription to your door this week. The other is built to run your whole midlife care. Those are different purchases.
By Franky Wilder · Reviewed by Michael Peters, MD · Last reviewed: September 2026 · 9 min read
✓ Medically Reviewed by Michael Peters, MD (Retired Physician, Metabolic & Hormonal Health)
NOT MEDICAL ADVICE
This comparison is for educational purposes only. It does not constitute a medical recommendation, diagnosis, or treatment plan. The right choice depends on your individual health history, current medications, and clinical profile. Consult a qualified healthcare provider before making any changes to your health regimen.
TL;DR
- Alloy and Midi Health both prescribe FDA-approved hormone therapy online, but through opposite service models: Alloy is a cash-pay subscription built for speed, Midi is an insurance-based virtual clinic built for depth.
- Alloy starts with an intake questionnaire reviewed by a menopause-trained physician; Midi starts with a scheduled video visit with a menopause-trained clinician.
- Midi's lane is wider — labs, non-hormonal options, and metabolic care where clinically appropriate. Alloy's lane is narrower and faster.
- Both require clinician evaluation before any prescription. Neither replaces your own doctor.
- The honest read: pick the model that matches the size of the question you're carrying — a refill-shaped question or a whole-chart-shaped one.
WHAT THIS IS NOT
- Not a medical recommendation. The right platform depends on your individual health history.
- Not a ranking based on payment. Midi Health is our vetted affiliate partner. Alloy is not in our partner network — and this page evaluates both on the merits.
- Not a substitute for working with a provider who knows your history.
Two Doors Into the Same Building
Alloy and Midi Health both prescribe FDA-approved hormone therapy online — but Alloy is built for prescription speed on a cash-pay subscription, while Midi is built as an insurance-based virtual clinic. Search results flatten them into the same category, "menopause telehealth," which is roughly as useful as filing an urgent-care clinic and a specialist practice under the same sign.
The distinction that matters is not which company is better. It is which service model matches your situation: how fast you need to move, how complicated your health picture is, and whether your insurance card should be doing some of the work.
How They Compare
| Feature | Midi Health | Alloy |
|---|---|---|
| What they do | Virtual menopause clinic — scheduled clinician visits | Online menopause Rx service — questionnaire-first |
| Approach | Care-plan model: visit, labs where indicated, follow-up | Speed model: intake reviewed by a menopause-trained physician |
| HRT available | Yes — FDA-approved options where appropriate | Yes — FDA-approved options where appropriate |
| Beyond hormones | Non-hormonal Rx, metabolic and GLP-1 conversations where clinically appropriate | Adjacent Rx (skin, sexual health) — narrower clinical lane |
| Insurance | Bills many major plans (varies by state and plan) | Cash-pay — treatment not billed to insurance |
| HSA/FSA | Typically eligible — confirm with your plan | Typically eligible — confirm with your plan |
| Best for | Complex or multi-symptom picture; insurance doing the work | A focused hormone question you want answered fast |
| Vetted partner | ✅ Yes | Not currently |
| Next step | Review the Midi Care Path → | Alloy's site → |
Midi Health: The Clinic Model
Midi Health is built like a specialist clinic that happens to live on a screen. You book a video visit with a clinician trained specifically in perimenopause and menopause care, walk through your history and symptoms, and leave with a care plan — which may include FDA-approved hormone therapy, non-hormonal prescriptions, lab work where indicated, and scheduled follow-up. Where metabolic concerns sit alongside hormonal ones, that conversation happens inside the same visit rather than getting bounced to another provider.
The structural advantage is insurance: Midi bills many major plans for its visits, which changes both the economics and the character of the care — a covered clinical relationship rather than a subscription you re-evaluate every month. If you have spent years being told your labs are normal while feeling anything but, the appeal of a clinician whose entire caseload is midlife hormonal change is not cosmetic. It is the difference between explaining perimenopause to your provider and being understood on the first sentence.
Hormone therapy and prescription treatment are not appropriate for everyone. Candidacy depends on your personal and family health history, and is determined by a licensed clinician — not by a comparison page.
This article contains some affiliate links. Menopossy may earn a commission if you purchase through them — at no additional cost to you. This does not affect our editorial position. Evidence tier labels reflect our independent assessment of the research, not the commercial relationship.
Midi Health — Insurance-Based Menopause Care
Menopossy gives you the clarity. Midi gives you access to care — a clinician whose entire practice is the decade your twelve-minute annual visit keeps skipping.
THE PATH: A scheduled visit with a menopause-trained clinician, billed to insurance where covered. Evaluation first — prescriptions only where clinically appropriate.
Midi connects you with clinicians who specialize in perimenopause and menopause, coordinate labs where indicated, and build a follow-up plan — hormonal, non-hormonal, and metabolic lanes under one roof.
Review the Midi Care Path →Tier A — Clinical Care | Affiliate
Alloy: The Speed Model
Alloy solved a different problem: the gap between deciding you want hormone therapy evaluated and actually holding a prescription. Its model starts with a detailed intake questionnaire reviewed by a menopause-trained physician, moves asynchronously by default, and ships FDA-approved treatments — estradiol in several forms, micronized progesterone, vaginal estradiol, and adjacent prescriptions for skin and sexual health — on a cash-pay subscription. Ongoing messaging with the prescribing physician is part of the service.
The trade is explicit. You get speed and simplicity; you give up the wider clinical conversation. Alloy is not built to run your labs, manage a complicated multi-condition picture, or bill your insurance. For a woman with an uncomplicated history and a focused hormone question, that narrowness is the feature. For a woman whose symptom picture sprawls across sleep, mood, metabolism, and a family history with asterisks, it is the limitation.
A questionnaire-based model still ends in a physician's judgment: Alloy's doctors decline to prescribe where history makes hormone therapy inappropriate. Speed changes the interface, not the clinical bar.
Alloy — Fast-Track Hormone Rx
Alloy is not currently in our vetted affiliate partner network. We evaluate partners on clinical integrity, evidence standards, and alignment with our editorial position — and this page's assessment of Alloy is unaffected by that status.
You can learn more via Alloy's site.
How to Choose Between Them
You do not need to become a clinician to make this call. You need an honest read on two things: how complicated your health picture actually is, and how you want to pay. Neither answer is a verdict on you. It is a routing decision.
CONSIDER MIDI HEALTH IF
- Your symptom picture spans several systems — sleep, mood, metabolism, vasomotor — and you want one clinician holding the whole thread.
- Your health history has complexity a questionnaire flattens: prior conditions, current medications, family history that deserves a live conversation.
- You have insurance you would rather use than ignore, and a covered clinical relationship matters to you.
CONSIDER ALLOY IF
- Your question is focused — a specific, well-understood hormone therapy need — and speed to treatment is the priority.
- Your history is uncomplicated and you are comfortable with an asynchronous, questionnaire-first evaluation by a physician.
- Cash-pay subscription pricing works for you, or insurance is not an option you can lean on.
These are considerations, not directives. The right choice depends on your clinical profile and a conversation with a physician.
Questions to Bring to Your First Contact
Whichever door you walk through, the evaluation goes better when the questions are already written down. You are not there to be processed. You are there to be evaluated — and good questions shift the dynamic from checkout to consult.
- "Based on my history, am I a candidate for hormone therapy — and what would rule me out?"
- "What do you assess before prescribing — symptoms alone, or labs as well, and which ones?"
- "How do you decide between transdermal and oral delivery for someone with my profile?"
- "What does follow-up look like — who adjusts my protocol, and on what schedule?"
- "If my picture turns out to be more complicated than the intake suggested, what happens — referral, visit, or discharge?"
- "How does this treatment coordinate with my existing OB-GYN or primary care?"
- "What would make you change or stop a protocol?"
DO NOT ACCEPT
- A prescription issued with no stated plan for follow-up, monitoring, or adjustment — from any platform, at any speed.
- "Your labs are normal, so there's nothing to treat." Normal is a population range, not your baseline.
- Pressure to subscribe before a clinician has actually reviewed your history.
- "Hormone therapy is too risky to discuss." Risk is individual and worth an actual conversation — not a blanket refusal.
You are entitled to a clinical conversation, not a dismissal.
The Bottom Line
VETTED PARTNER — CLINIC MODEL
Midi Health is the depth choice: a scheduled visit with a menopause-trained clinician, insurance billing where covered, and a care plan wide enough to hold hormones, non-hormonal options, and metabolic concerns together.
NOT IN OUR PARTNER NETWORK — SPEED MODEL
Alloy is the speed choice: physician-reviewed, FDA-approved hormone therapy on a cash-pay subscription, best matched to a focused question and an uncomplicated history.
Speed and depth are both legitimate things to want from midlife care — the mistake is buying one while needing the other. Know which question you are actually carrying before you pick the door built to answer it.
If you're not sure which applies to you — the Bio-Audit maps the full picture. For the clinical background on what hormone therapy does and does not address, start with the HRT protocol guide, or compare all providers.
IMPORTANT
If you are experiencing chest pain, severe acute symptoms, or a medical emergency — go to an ER. This page is not emergency care.
Frequently Asked Questions
Does Alloy take insurance?
Alloy is a cash-pay subscription service — treatment costs are not billed to insurance, though HSA/FSA funds can often be used. Midi Health, by contrast, bills many major insurance plans for its clinician visits. Confirm current coverage details directly with each platform and your plan.
Is Alloy's hormone therapy FDA-approved?
Alloy prescribes FDA-approved hormone therapy products, including estradiol and micronized progesterone, where a physician determines they are clinically appropriate. FDA approval applies to the medications; whether hormone therapy fits your health history is an individual clinical question for a licensed prescriber.
Which is faster to start, Alloy or Midi?
Alloy's model is built around an intake questionnaire reviewed by a menopause-trained physician, which typically moves faster than booking a scheduled visit. Midi's model is built around a live video appointment, which takes longer to reach but covers a broader clinical conversation. Speed and depth are the trade the two models make.
Do I need to leave my current doctor to use Alloy or Midi?
No. Both platforms function as specialist telehealth services, not primary care replacements. Your existing provider relationship should continue — these platforms work best as additions to your current care, not substitutes for it.
Sources
The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause, 2022;29(7):767–794.
Why this matters: the clinical baseline both platforms prescribe against — what hormone therapy is indicated for, and for whom candidacy must be individually assessed.
Kling JM, et al. Menopause management knowledge in postgraduate trainees. Mayo Clinic Proceedings, 2019;94(2):242–253.
Why this matters: documents the menopause-training gap in general medicine that specialist telehealth platforms exist to fill.
U.S. Food and Drug Administration — approved menopausal hormone therapy products (estradiol, micronized progesterone). fda.gov.
Why this matters: both platforms' hormone offerings discussed here are FDA-approved products; approval status is a checkable fact, not a marketing claim.
This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendation. Franky Wilder is not a licensed physician or clinician. Always consult a qualified healthcare provider before making changes to your health regimen. Menopossy maintains an affiliate relationship with Midi Health. Alloy is not an affiliate partner. Our editorial content is never influenced by commercial relationships.